stella
beta
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) — Stella
Recruiting
Back to Bladder Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(3 sites)
United States
TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822), Cincinnati, Ohio
Thompson Cancer Survival Center ( Site 0803), Knoxville, Tennessee
Israel
Shaare Zedek Medical Center ( Site 0366), Jerusalem
View full record on ClinicalTrials.gov